Previous close | 0.0100 |
Open | 0.0100 |
Bid | 0.0000 |
Ask | 0.2700 |
Strike | 260.00 |
Expiry date | 2024-11-15 |
Day's range | 0.0100 - 0.0100 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AbbVie's (ABBV) Skyrizi is now approved for four indications across immune-mediated inflammatory diseases.